Kidney Cancer Trial, Recruiting (NCT06652022)

Kidney Cancer Trial, Recruiting NCT06652022 Sponsor: Peking University First Hospital Condition: Kidney Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06652022 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Kidney Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with metastatic urothelial cancer (a type of cancer affecting the urinary tract lining) that has been confirmed by a tissue sample (biopsy) from either the original tumour or one of the areas it has spread to.
Your cancer has spread to no more than 3 different organs, and the areas of spread can be fully covered by radiation therapy.
You are between 18 and 80 years old and are willing to sign a consent form to take part.
Your doctors expect you to live for at least 6 more months.
You are generally able to carry out daily activities with little to no limitation (confirm with trial site what this means for your specific situation).
Your blood counts, liver function, and kidney function meet certain minimum levels as shown in your recent blood tests (confirm exact values with trial site).

Who may not be able to join:

Your cancer is not the urothelial (urinary tract lining) type.
You have cancer that has spread to the brain, or more than 3 spots in the liver, or spine metastases that risk pressing on the spinal cord, or you have fluid build-up around the heart, lungs, or abdomen.
You have not been able to tolerate your current cancer treatment, needed a dose reduction, or your cancer was found to be getting worse after 2 cycles of treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06652022

Sponsor: Peking University First Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Kidney Cancer

More information: https://clinicaltrials.gov/study/NCT06652022

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with metastatic urothelial cancer (a type of cancer affecting the urinary tract lining) that has been confirmed by a tissue sample (biopsy) from either the original tumour or one of the areas it has spread to.
Your cancer has spread to no more than 3 different organs, and the areas of spread can be fully covered by radiation therapy.
You are between 18 and 80 years old and are willing to sign a consent form to take part.
Your doctors expect you to live for at least 6 more months.
You are generally able to carry out daily activities with little to no limitation (confirm with trial site what this means for your specific situation).
Your blood counts, liver function, and kidney function meet certain minimum levels as shown in your recent blood tests (confirm exact values with trial site).

Who may not be able to join:

Your cancer is not the urothelial (urinary tract lining) type.
You have cancer that has spread to the brain, or more than 3 spots in the liver, or spine metastases that risk pressing on the spinal cord, or you have fluid build-up around the heart, lungs, or abdomen.
You have not been able to tolerate your current cancer treatment, needed a dose reduction, or your cancer was found to be getting worse after 2 cycles of treatment.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Peking University First Hospital

Registry

ClinicalTrials.gov

Start date

1 January 2022

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov